Discoid Lupus Erythematosus Clinical Trial
Official title:
Exploratory Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus
The purpose of this study is to assess the potential efficacy of topical ruxolitinib for the treatment of discoid lupus erythematosus (DLE)
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03866317 -
A Study to Assess the Safety and Efficacy of Secukinumab in Alleviating Symptoms of Discoid Lupus Erythematosus
|
Phase 2 | |
Completed |
NCT00001680 -
A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus
|
Phase 2 | |
Recruiting |
NCT05591222 -
Study of Daxdilimab (HZN-7734) in Patients With Moderate-to-Severe Primary Discoid Lupus Erythematosus
|
Phase 2 | |
Completed |
NCT00625521 -
Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions
|
Phase 2 | |
Completed |
NCT02125695 -
Pilot Tape Harvesting Study
|
N/A | |
Completed |
NCT05362188 -
Topical Nicotinamide in Treatment of DLE
|
Early Phase 1 | |
Completed |
NCT00708916 -
Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients
|
Phase 1/Phase 2 | |
Terminated |
NCT03958955 -
Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.
|
Phase 2 | |
Terminated |
NCT03159936 -
Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)
|
Early Phase 1 | |
Completed |
NCT00691769 -
Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia
|
||
Completed |
NCT00608673 -
Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus
|
N/A | |
Recruiting |
NCT06261021 -
Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects With Discoid Lupus Erythematosus
|
Phase 2 | |
Completed |
NCT00625157 -
Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)
|
Phase 2 |